Analysts expect Century Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 791,000.00 | 4.18 M | 109.16 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 442,704.27 | 828,603.02 | 40.98 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -71,360.51 | -19,501.30 | 7.12 M | -8.62 M | ||||||||||
| Low Estimate | 400,683.33 | 777,486.02 | 36.60 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -84,464.79 | -23,399.48 | 6.64 M | -9.52 M | ||||||||||
| Consensus Estimate | 421,693.80 | 803,044.52 | 38.79 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -77,912.65 | -21,450.39 | 6.88 M | -9.07 M |
Analysts expect Century Therapeutics, Inc. to report earnings per share of -0.11 for Q3 26, against a range of -0.12 to -0.10. The most recent reported quarter, Q2 26, came in at -0.17, a 70.0% miss against the -0.10 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.37 | -0.41 | 0.89 | -0.38 | -0.40 | -0.25 | -0.11 | -0.17 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.41 | -0.39 | -0.01 | -0.35 | -0.33 | -0.27 | -0.15 | -0.10 | -0.10 | -0.11 | -0.12 | -0.11 | -0.08 | -0.06 | -0.01 | -0.21 | ||||||||||
| Low Estimate | -0.47 | -0.45 | -0.01 | -0.39 | -0.37 | -0.29 | -0.17 | -0.10 | -0.12 | -0.13 | -0.14 | -0.13 | -0.08 | -0.06 | -0.01 | -0.25 | ||||||||||
| Consensus Estimate | -0.44 | -0.42 | -0.01 | -0.37 | -0.35 | -0.28 | -0.16 | -0.10 | -0.11 | -0.12 | -0.13 | -0.12 | -0.08 | -0.06 | -0.01 | -0.23 |
Pull Wall Street consensus for Century Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IPSC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IPSC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IPSC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();